Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




image: Ataraxis Breast CTX combines H&E pathology slides with clinical data to generate patient-specific prognostic and predictive outputs (photo courtesy of Ataraxis AI)

AI Tool Predicts Patient-Specific Chemotherapy Benefit in Breast Cancer

A newly launched AI test estimates individualized chemotherapy benefit at the patient level, offering more precise support for treatment planning. More...
01 Apr 2026
Image: The EvORanker AI algorithm narrows thousands of candidate genes to the most probable disease-causing target (photo credit: 123RF)

New AI Tool Improves Detection of Genetic Causes in Rare Disorders

A new AI tool accelerates the identification of genetic causes underlying rare diseases. More...
01 Apr 2026
image: The new findings provides critical genetic information to understand how SDSE spreads, evolves, and causes infection, with insights intended to support diagnosis, infection control, and vaccine planning (photo credit: 123RF)

Genomic Analysis Links Emerging Streptococcal Strains to Specific Infections

Researchers have identified 44 variants of a rising Streptococcal pathogen, offering insights to support diagnosis and infection control. More...
01 Apr 2026
Image: The collaboration focuses on verified automation methods for Takara Bio USA’s SMART-Seq library preparation kits on Hamilton’s Microlab STAR Liquid Handling Systems (photo courtesy of Hamilton Company)

Takara Bio USA and Hamilton Partner Partner to Automate NGS Library Preparation

Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., and Hamilton Company announced a development and co-marketing agreement to deliver integrated, automated next-generation sequencing (NGS) library preparation workflows. More...
01 Apr 2026
image: Ataraxis Breast CTX combines H&E pathology slides with clinical data to generate patient-specific prognostic and predictive outputs (photo courtesy of Ataraxis AI)

AI Tool Predicts Patient-Specific Chemotherapy Benefit in Breast Cancer

A newly launched AI test estimates individualized chemotherapy benefit at the patient level, offering more precise support for treatment planning. More...
01 Apr 2026
Image: The direct-from-urine rapid method can identify an effective antibiotic in an average of 5.85 hours (photo courtesy of Shutterstock)

Rapid Urine Test Speeds Antibiotic Selection for UTIs

A novel antibiotic susceptibility testing method delivers actionable results directly from urine within hours. More...
31 Mar 2026
Image: Study cohorts, deep learning system architecture, and performance evaluation on TAILORx-Test (Shamai G, Cohen S, Binenbaum Y et al., Lancet Oncology, 2026; . DOI: 10.1016/s1470-2045(25)00727-2)

AI-Based Pathology Model Guides Chemotherapy Decisions in Breast Cancer

An AI approach predicts both recurrence risk and the likelihood of chemotherapy benefit using routine pathology slides. More...
31 Mar 2026
New
Gold Member
Aspiration System
VACUSAFE
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
HPV Test
Allplex HPV28 Detection
New
Electrolyte Analyzer
BKE-B
Copyright © 2000-2026 Globetech Media. All rights reserved.